Co-Diagnostics EVP Finance and Accounting Daniel Bohrer files initial beneficial ownership statement
Reuters2026/09/14 22:50- Co-Diagnostics EVP of Finance & Accounting Daniel Bohrer filed an initial Form 3 reporting 3,657 common shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GLJ gives GE Vernova (GEV.US) a "Sell" rating: $470 target price is the lowest on Wall Street, bluntly stating that "cyclical industrial stocks are being priced like software stocks"
GLJ Research has given GE Vernova a "sell" rating and set the lowest target price on Wall Street at $470, stating that the company is "a cyclical gas turbine manufacturer priced like a long-term compound growth stock."
Data: US XRP spot ETF saw a net inflow of 11.255 million USD in a single day
Delta Thailand returns to FTSE4Good ESG index for eighth time
Impact Biomedical to execute 1-for-12.62 reverse stock split Sept. 23
Crypto prices
More
